BioAge Labs
0 followers
BIOA
Performance
About BioAge Labs
BioAge Labs is a biotechnology company focused on developing therapies that target the biology of human aging to treat cardiometabolic diseases. The company builds a pipeline of aging-focused programs, including lead candidates such as BGE-102, an NLRP3 inhibitor aimed at reducing chronic inflammation linked to cardiovascular risk and metabolic dysfunction. Its discovery platform analyzes multi-omics data to identify aging-related mediators and disease pathways, guiding pipeline programs that address metabolic aging. Headquartered in Emeryville, California, BioAge Labs operates at the intersection of aging research and metabolic disease therapeutics.
Recent News
No recent news for this company.
Recent Deals
No recent deals for this company.